• DSHS HIV/STD Program

    Post Office Box 149347, MC 1873
    Austin, Texas 78714

    Phone: (737) 255-4300

    Email the HIV/STD Program

    Email data requests to HIV/STD Program - This email can be used to request data and statistics on HIV, TB, and STDs in Texas. It cannot be used to get treatment or infection history for individuals, or to request information on programs and services. Please do not include any personal, identifying health information in your email such as HIV status, Date of Birth, Social Security Number, etc.

    For treatment/testing history, please contact your local Health Department.

    For information on HIV testing and services available to Persons Living with HIV and AIDS, please contact your local HIV services organization.

Pre-Exposure Prophylaxis (PrEP) for Providers


Texas DSHS recommends that pre-exposure prophylaxis (PrEP) be considered for people who are at elevated risk for acquiring HIV. PrEP involves the use of daily oral antiretroviral medication to help prevent HIV acquisition, and is recommended for use in conjunction with other prevention measures, such as barrier methods. PrEP has been extensively studied [CDC] and found to be safe and effective.

The medication that is currently approved by the U.S. Food and Drug Administration (FDA) for use as PrEP is the fixed-dose combination of emtricitabine (FTC) 200 mg and tenofovir disoproxil fumarate (TDF) 300 mg, marketed under the trade name Truvada®. It is given as a single daily dose and is FDA-approved for use in healthy adolescents and adults who are at elevated risk of acquiring HIV infection and who weigh at least 35 kilograms (77 pounds).

To learn more about how to prescribe PrEP and nPEP or for support for your clinical practice, visit Prescribe HIV Prevention [CDC] or call the National Clinical Consultation Center [UCSF] directly at (855) 448-7737 for PrEP consultations and (888) 448-4911 for nPEP consultations. 

The Provider’s Role

Any licensed healthcare provider with prescribing authority can write prescriptions for daily PrEP. 

Below are some steps you can take to play a role in the goal of reducing HIV transmission and acquisition statewide:

  1. Take a comprehensive sexual history [CDC] (PDF) from all patients as a part of routine medical care.

  2. Screen patients with elevated risk for HIV and other STDs based on sexual history and clinical practice guidelines [CDC] (PDF).                                                                                                          

  3. Talk about PrEP with patients at elevated risk of acquisition, patients who request the intervention by name, and patients living with HIV with mixed status sex or drug use partners.

  4. Prescribe PrEP according to clinical practice guidelines [CDC] (PDF), or refer patients to sites that provide PrEP. Visit the Texas DSHS PrEP Directory or the National Prevention Information Network Directory for a listing of clinics and providers who prescribe PrEP near you
     

Support for PrEP

Texas DSHS supports PrEP as a highly effective intervention for HIV Prevention:

PrEP is supported by the following entities:

Clinical Resources and Tools

Continuing Education

Other Resources

Pre-exposure Prophylaxis for the public



Last updated June 16, 2020